INVISION acquires equity interests in the Dr. Deppe Group

Dr Deppe Group is one of Germany’s leading developers and producers of clinical disinfectants as well as cleaning products and wet wipes.

The Company headquartered in Kempen, has over 90 employees and was founded in 1980 by Dr Hans Dieter Deppe. Since its inception, the business has been managed by Deppe family members and has successfully grown, both domestically and internationally.

Laboratorium Dr Deppe develops and produces specialized predominantly private label disinfectants and cleaning consumables serving the outpatient-care market. Disinfectants and biocidal products are distributed predominantly to clinics, labs and general practitioners.

The broad product portfolio addresses hygiene for skin and hands, surfaces, as well as medical instruments and applications.

Dr Deppe’s inhouse R&D and lab enables the rapid development and market introduction of innovative products. It has for instance enabled the company to secure a leading position in the growing market for wet wipe disinfectants.

Invision invested in Dr Deppe Group to support further growth. Over the coming years the objective is to expand the production in Kempen and continue the international expansion of revenues. Targeted acquisitions will be considered, with Invision open to investing additional capital.

Peter Kroha, Partner of Invision and Head of Germany: “Invision’s investment in Dr Deppe Group is the second transaction within the last 10 months in North Rhein Westphalia. We are delighted to have the opportunity, together with the Deppe family and the management team, to participate in the continued development of this exciting company. Dr Deppe represents a further prime example of a high quality, family run German Mittelstand business.”

The CEO of the business, Titus Deppe, will continue to run the company together with his colleagues Oktay Cakmakci und Dr Mark Derks.

Titus Deppe, CEO: “As a traditional family owned business, it was important for us to find a partner who shares our vision, understands our company culture and appreciates the values of the German Mittelstand. With INVISION, we believe we have found a partner willing to support the continued growth profile with the same level of enthusiasm as our family has done for generations.”


Dr Deppe Group, including Laboratorium Dr. Deppe GmbH, Synersis GmbH and Cosmed GmbH headquartered in Kempen, employs over 90 FTEs and is a leading manufacturer of clinical disinfectants, professional cleaning products and wet wipes in Germany. Founded in 1980, Dr Deppe Group has since focused, on ensuring its customers receive high quality innovative products.

Further information is available on the websites: www.dr-deppe.de and www.synersis.de.

Contact Us


    Invision AG
    Grafenaustrasse 7
    6300 Zug

    T +41 41 729 01 01
    F +41 41 729 01 00
    E info(at)invision.ch


    Invision Beteiligungsberatung GmbH
    Grünstraße 23
    40212 Düsseldorf

    T +49 211 936 727 50
    F +49 211 936 727 59
    T info(at)invision.ch